CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
0.0951
-0.0047 (-4.71%)
At close: Jan 31, 2025, 4:00 PM
0.0963
+0.0012 (1.26%)
After-hours: Jan 31, 2025, 7:58 PM EST
CNS Pharmaceuticals Employees
As of December 31, 2023, CNS Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,411,337
Market Cap
5.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5 | 0 | - |
| Dec 31, 2022 | 5 | 0 | - |
| Dec 31, 2021 | 5 | 0 | - |
| Dec 31, 2020 | 5 | 0 | - |
| Dec 31, 2019 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
CNSP News
- 2 months ago - CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024 - Accesswire
- 2 months ago - CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy - Accesswire
- 2 months ago - CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024) - Accesswire
- 2 months ago - CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results - Accesswire
- 3 months ago - CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment - Accesswire
- 3 months ago - CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Accesswire
- 3 months ago - CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - Accesswire
- 4 months ago - CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment - Accesswire